Related references
Note: Only part of the references are listed.Drug repositioning against COVID-19: a first line treatment
Nousheen Bibi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Olfactory regulation by dopamine and DRD2 receptor in the nose
Hai-Qian Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity
Giuseppe Bombaci et al.
LIFE SCIENCE ALLIANCE (2022)
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
COVID-19 and neurocognitive disorders
Elizabeta B. Mukaetova-Ladinska et al.
CURRENT OPINION IN PSYCHIATRY (2021)
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
Mohamed M. Aboudounya et al.
MEDIATORS OF INFLAMMATION (2021)
Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis
Serge Nataf et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition
Xiaolei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step
Shiu-Wan Chan et al.
VIRUSES-BASEL (2021)
SARS-CoV-2 spike protein interacts with and activates TLR41
Yingchi Zhao et al.
CELL RESEARCH (2021)
Amantadine Inhibits SARS-CoV-2 In Vitro
Klaus Fink et al.
VIRUSES-BASEL (2021)
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
Manuel Hayn et al.
CELL REPORTS (2021)
Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Yifei Feng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Activation of Dopamine D2 Receptor Alleviates Neuroinflammation in a Mouse Model of Allergic Rhinitis With Olfactory Dysfunction
Peiqiang Liu et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2021)
Tyrosine hydroxylase conditional KO mice reveal peripheral tissue-dependent differences in dopamine biosynthetic pathways
Katsuya Miyajima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Docking Prediction of Levodopa in the Receptor Binding Domain of Spike Protein of SARS-CoV-2
Abdul Mannan Baig et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)
Inactivation of Material from SARS-CoV-2-Infected Primary Airway Epithelial Cell Cultures
Kaitlyn A. Barrow et al.
METHODS AND PROTOCOLS (2021)
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
S. M. Matt et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2020)
An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19
Serge Nataf
JOURNAL OF MEDICAL VIROLOGY (2020)
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Ulf Andersson et al.
MOLECULAR MEDICINE (2020)
Antiviral activities of type I interferons to SARS-CoV-2 infection
Emily Mantlo et al.
ANTIVIRAL RESEARCH (2020)
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel et al.
FRONTIERS IN PHARMACOLOGY (2020)
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment
Konrad Rejdak et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Inhibition of SARS-CoV-2 by type I and type III interferons
Ulrike Felgenhauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Activation and evasion of type I interferon responses by SARS-CoV-2
Xiaobo Lei et al.
NATURE COMMUNICATIONS (2020)
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2020)
Is COVID-19 a Perfect Storm for Parkinson's Disease?
Patrik Brundin et al.
TRENDS IN NEUROSCIENCES (2020)
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
Idoia Busnadiego et al.
MBIO (2020)
A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?
Irma Saulle et al.
CELLS (2020)
Determining the relationship between SARS-CoV-2 infection
Muad M. Khalefah et al.
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES (2020)
Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis
Fiona Limanaqi et al.
ANTIOXIDANTS (2020)
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
Kyung Mok Sohn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Cell Clearing Systems Bridging Neuro-Immunity and Synaptic Plasticity
Fiona Limanaqi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biased signaling agonist of dopamine D3 receptor induces receptor internalization independent of β-arrestin recruitment
Wei Xu et al.
PHARMACOLOGICAL RESEARCH (2019)
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Andrew J. Haak et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3
Jialei Zhu et al.
CELL DEATH AND DIFFERENTIATION (2018)
Dopamine Receptor Subtypes Differentially Regulate Autophagy
Dongmei Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Dopamine regulates cytokine secretion during innate and adaptive immune responses
Masaaki Kawano et al.
INTERNATIONAL IMMUNOLOGY (2018)
Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease
Akanksha Mishra et al.
JOURNAL OF EXPERIMENTAL NEUROSCIENCE (2018)
Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells
Yogy Simanjuntak et al.
FRONTIERS IN MICROBIOLOGY (2017)
Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication
Daria Trabattoni et al.
SCIENTIFIC REPORTS (2016)
Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia
Patrick Ejlerskov et al.
CELL (2015)
Dopamine Controls Systemic Inflammation through Inhibition of NLRP3 Inflammasome
Yiqing Yan et al.
CELL (2015)
A comprehensive transcriptional portrait of human cancer cell lines
Christiaan Klijn et al.
NATURE BIOTECHNOLOGY (2015)
THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION
C. P. Ford
NEUROSCIENCE (2014)
Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages
Peter J. Gaskill et al.
PLOS ONE (2014)
Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens
Catarina A. Owesson-White et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Neurotensin Triggers Dopamine D2 Receptor Desensitization through a Protein Kinase C and β-Arrestin1-dependent Mechanism
Dominic Thibault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Endocytosis Promotes Rapid Dopaminergic Signaling
Sarah J. Kotowski et al.
NEURON (2011)
The immunoregulatory role of dopamine: An update
Chandrani Sarkar et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D2 Dopamine Receptor
Yoon Namkung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Arrestin3 Mediates D2 Dopamine Receptor Internalization
Mette Skinbjerg et al.
SYNAPSE (2009)
Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer
Daniele Campa et al.
LUNG CANCER (2007)
The effects of dopamine on the respiratory system: Friend or foe?
Agnieszka Ciarka et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Dopamine regulation of amiloride-sensitive sodium channels in lung cells
MN Helms et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation
D Ferone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
The dopamine paradox in lung and kidney epithelia - Sharing the same target but operating different signaling networks
AM Bertorello et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
Dopamine responsiveness is regulated by targeted sorting of D2 receptors
SE Bartlett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment
SJ Tsai
MEDICAL HYPOTHESES (2004)
Dopamine increases lung liquid clearance during mechanical ventilation
FJ Saldías et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Complexity of agonist- and cyclic AMP-mediated downregulation of the human β1-adrenergic receptor:: Role of internalization, degradation, and mRNA destabilization
CD Dunigan et al.
BIOCHEMISTRY (2002)
Agonist-mediated down-regulation of rat β1-adrenergic receptor transcripts:: Role of potential post-transcriptional degradation factors
P Kirigiti et al.
MOLECULAR PHARMACOLOGY (2001)
Share Paper
